Ascendis Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	84,959	68,383	42,628	36,858	35,352	38,127
Market Cap Growth	-	60.42%	15.65%	4.26%	-7.28%	-17.80%
Enterprise Value	86,896	69,936	44,227	38,259	34,092	34,732
PS Ratio	16.31	15.64	21.77	24.16	124.47	833.13
PB Ratio	28.95	-69.18	-74.90	-44.23	24.19	7.33
P/TBV Ratio	11.56	-	-	-	26.49	8.39
P/FCF Ratio	313.92	209.00	-	-	-	-
P/OCF Ratio	233.51	209.00	-	-	-	-
EV/Sales Ratio	16.78	16.00	22.59	25.08	120.03	758.93
EV/FCF Ratio	321.07	213.74	-	-	-	-
Debt / Equity Ratio	0.79	-2.37	-3.45	-1.53	1.83	0.11
Debt / EBITDA Ratio	87.54	-	-	-	-	-
Debt / FCF Ratio	14.82	16.18	-	-	-	-
Net Debt / Equity Ratio	0.66	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	31.62	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	5.35	4.75	-0.97	-0.52	0.46	1.31
Asset Turnover	0.52	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.10	-0.32	-0.18	0.26	-0.12	-0.09
Quick Ratio	0.68	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.00	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	305.05%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	1.30%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	1.39%	-13.90%	-33.32%	-90.87%	-190.06%	-147.02%
Return on Capital Employed (ROCE)	-1.31%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
FCF Yield	0.32%	0.48%	-	-	-	-
Buyback Yield / Dilution	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%